Teva Pharma Announces Launch Of Generic Symbyax In U.S.

Teva, Alexa Announce Exclusive U.S. License And Supply Deal For ADASUVE

Teva First Quarter Results Top Estimates

Teva Q1 Profit Down - Quick Facts

Teva Pharmaceutical Industries Q1 13 Earnings Conference Call At 8:00 AM ET

Trade TEVA now with

6/21/2012 1:33 PM ET

Teva Pharmaceutical Industries Ltd. (TEVA: Quote) announced the launch of Olanzapine and Fluoxetine Capsules USP 6 mg/25 mg, 12 mg/25 mg, 6 mg/50 mg, and 12 mg/50 mg, the Company's generic equivalent of Symbyax.

Symbyax is marketed by Lilly USA and approved for the acute treatment of treatment-resistant depression and bipolar I depression in adults. The brand product had annual sales of about $82 million in the United States, based on IMS sales data.

Click here to receive FREE breaking news email alerts for Teva Pharmaceutical Industries Limited and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

42 Articles Next>>

Editors Pick

Stocks May Give Back Ground In Early Trading - U.S. Commentary

After showing a strong upward move last week, stocks may give back some ground in early trading on Monday. The major index futures are currently pointing to a modestly lower open for the markets, with the Dow futures down by 23 points.

Thailand Cuts 2013 GDP Outlook As Q1 Growth Slows More Than Expected

Thailand lowered its full-year growth outlook after weaker domestic demand and exports weighed on economic activity in the first three months of the year. Gross domestic product expanded 5.3 percent year-on-year in the first quarter of 2013 compared to an upwardly revised 19.1 percent growth in the fourth quarter of 2012, the National Economic and Social Development Board (NESDB) said Monday.

U.K. House Prices Hit Record High: Rightmove

The fifth consecutive monthly increase in the U.K. house prices amid limited supply took average asking prices to a record, a survey by Rightmove showed Monday. House prices hit a record GBP 249,841 in May, as new sellers raised their prices by 2.1 percent from the prior month. Prices were up by the same magniture in April.